Competing interests
EMA
SJM has served as a consultant to Allergan, Alkermes, Almatica, Axsome Therapeutics, Biohaven, BioXcel Therapeutics, Clexio Biosciences, Eleusis, EMA Wellness, Engrail Therapeutics, Greenwich Biosciences, Intra-Cellular Therapies, Janssen, Levo Therapeutics, Perception Neurosciences, Neurocrine, Relmada Therapeutics, Sage Therapeutics, Seelos Therapeutics, Signant Health, and Sunovion. He has served as an investigator for studies funded by Boehringer-Ingelheim, Janssen, Merck, Neurocrine, NeuroRx, and Sage Therapeutics, and has received research support from Biohaven Pharmaceuticals and VistaGen Therapeutics. NM has received research support from Neurocrine. ML has served as principal investigator for trials funded by NeuroRx, VistaGen Therapeutics, Ceruvia Lifesciences, and BrainsWay. ML is currently employed at Sage Therapeutics. The remaining authors have nothing to disclose. LAA has served as a consultant, speaker and/or advisory board member for Guidepoint, Transcend Therapeutics, Source Research Foundation, Reason for Hope, the Cohen Foundation, Beond and Ampelis.